203
Views
29
CrossRef citations to date
0
Altmetric
Original Research

Montmorillonite-norfloxacin nanocomposite intended for healing of infected wounds

, , , , , , , , , & show all
Pages 5051-5060 | Published online: 10 Jul 2019

Figures & data

Table 1 Fitting equation and parameters for the adsorption of NF onto VHS

Figure 1 Equilibrium adsorption isotherm of NF and VHS (mean values ± s.d.; n=3).

Abbreviations: NF, norfloxacin; VHS, montmorillonite.

Figure 1 Equilibrium adsorption isotherm of NF and VHS (mean values ± s.d.; n=3).Abbreviations: NF, norfloxacin; VHS, montmorillonite.

Figure 2 XRPD diffraction patterns of NF, VHS and VHS-NF.

Abbreviations: NF, norfloxacin; VHS, montmorillonite; VHS-NF, montmorillonite/norfloxacin nanocomposite.

Figure 2 XRPD diffraction patterns of NF, VHS and VHS-NF.Abbreviations: NF, norfloxacin; VHS, montmorillonite; VHS-NF, montmorillonite/norfloxacin nanocomposite.

Figure 3 FT-IR spectra of NF, VHS and VHS-NF.

Abbreviations: NF, norfloxacin; VHS, montmorillonite; VHS-NF: montmorillonite/norfloxacin nanocomposite.

Figure 3 FT-IR spectra of NF, VHS and VHS-NF.Abbreviations: NF, norfloxacin; VHS, montmorillonite; VHS-NF: montmorillonite/norfloxacin nanocomposite.

Figure 4 Thermal analysis (TGA – high panel curves and DSC – low panel curves) of NF, VHS and VHS-NF samples.

Abbreviations: NF, norfloxacin; VHS, montmorillonite; VHS-NF, montmorillonite/norfloxacin nanocomposite.

Figure 4 Thermal analysis (TGA – high panel curves and DSC – low panel curves) of NF, VHS and VHS-NF samples.Abbreviations: NF, norfloxacin; VHS, montmorillonite; VHS-NF, montmorillonite/norfloxacin nanocomposite.

Figure 5 TEM microphotographs and EDX analysis of VHS (A), NF (B) and VHS-NF (C) together with EDX mapping of VHS-NF (D).

Abbreviations: NF, norfloxacin; VHS, montmorillonite; VHS-NF, montmorillonite/norfloxacin nanocomposite.

Figure 5 TEM microphotographs and EDX analysis of VHS (A), NF (B) and VHS-NF (C) together with EDX mapping of VHS-NF (D).Abbreviations: NF, norfloxacin; VHS, montmorillonite; VHS-NF, montmorillonite/norfloxacin nanocomposite.

Figure 6 % of norfloxacin (NF) released from NF and VHS-NF (mean values ± s.d.; n=3).

Abbreviations: NF, norfloxacin; VHS-NF, montmorillonite/norfloxacin nanocomposite.

Figure 6 % of norfloxacin (NF) released from NF and VHS-NF (mean values ± s.d.; n=3).Abbreviations: NF, norfloxacin; VHS-NF, montmorillonite/norfloxacin nanocomposite.

Figure 7 Microbiocidal effect vs time profiles of norfloxacin (NF) released from NF and VHS-NF against (A) Pseudomonas aeruginosa and (B) Staphylococcus aureus (mean values ± s.d.; n=3).

Abbreviations: NF, norfloxacin; VHS-NF, montmorillonite/norfloxacin nanocomposite.

Figure 7 Microbiocidal effect vs time profiles of norfloxacin (NF) released from NF and VHS-NF against (A) Pseudomonas aeruginosa and (B) Staphylococcus aureus (mean values ± s.d.; n=3).Abbreviations: NF, norfloxacin; VHS-NF, montmorillonite/norfloxacin nanocomposite.

Figure 8 Bioavailability (OD) evaluated for VHS (1.2 mg/mL), NF (0.1 mg/mL) and VHS-NF (VHS: 1.2 mg/mL and NF 0.1 mg/mL) compared to the control (growth medium, standard growth conditions) (mean values ± s.d.; n=8) (Statistical analysis W test: control vs VHS-NF: p=0.030).

Abbreviations: NF, norfloxacin; VHS, montmorillonite; VHS-NF, montmorillonite/norfloxacin nanocomposite.

Figure 8 Bioavailability (OD) evaluated for VHS (1.2 mg/mL), NF (0.1 mg/mL) and VHS-NF (VHS: 1.2 mg/mL and NF 0.1 mg/mL) compared to the control (growth medium, standard growth conditions) (mean values ± s.d.; n=8) (Statistical analysis W test: control vs VHS-NF: p=0.030).Abbreviations: NF, norfloxacin; VHS, montmorillonite; VHS-NF, montmorillonite/norfloxacin nanocomposite.